News

Sistemic Ltd announce expansion of patent portfolio covering the use of microRNAs for quality assessment of stem cell therapy products by the granting of “Cell Characterisation” European patent No. EP2609217

Release Date: March 28, 2019

Sistemic Ltd announce expansion of patent portfolio covering the use of microRNAs for quality assessment of stem cell therapy products by the granting of “Cell Characterisation” European patent No. EP2609217

The European Patent Office communicated its decision to grant European Patent No. EP2609217, in the name of Sistemic Scotland Ltd titled “Cell Characterisation”.

The patent covers the use of microRNA profiles for quality assessment of stem cells and derived cell therapy products.

Pages